Al-Kuraya K - Search Results

1

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Jänicke F, Sauter G, Simon R. Holst F, et al. Nat Genet. 2007 May;39(5):655-60. doi: 10.1038/ng2006. Epub 2007 Apr 8. Nat Genet. 2007. PMID: 17417639

2

Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma.

Parvathareddy SK, Siraj AK, Annaiyappanaidu P, Siraj N, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS. Parvathareddy SK, et al. Front Endocrinol (Lausanne). 2023 Jan 4;13:1060301. doi: 10.3389/fendo.2022.1060301. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686467 Free PMC article.

3

Overexpression of the pro-protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF/MEK signaling.

Poyil PK, Siraj AK, Padmaja D, Parvathareddy SK, Diaz R, Thangavel S, Begum R, Haqawi W, Al-Mohanna FH, Al-Sobhi SS, Al-Dayel F, Al-Kuraya KS. Poyil PK, et al. Mol Oncol. 2023 Jul;17(7):1324-1342. doi: 10.1002/1878-0261.13396. Epub 2023 Feb 27. Mol Oncol. 2023. PMID: 36799665 Free PMC article.

4

Tissue microarrays for high-throughput molecular pathology.

Al Kuraya K, Simon R, Sauter G. Al Kuraya K, et al. Ann Saudi Med. 2004 May-Jun;24(3):169-74. doi: 10.5144/0256-4947.2004.169. Ann Saudi Med. 2004. PMID: 15307452 Free PMC article. Review.

5

HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies.

Tapia C, Schraml P, Simon R, Al-Kuraya KS, Maurer R, Mirlacher M, Novotny H, Spichtin H, Mihatsch MJ, Sauter G. Tapia C, et al. Int J Oncol. 2004 Dec;25(6):1551-7. Int J Oncol. 2004. PMID: 15547690 Clinical Trial.

6

Prognostic relevance of gene amplifications and coamplifications in breast cancer.

Al-Kuraya K, Schraml P, Torhorst J, Tapia C, Zaharieva B, Novotny H, Spichtin H, Maurer R, Mirlacher M, Köchli O, Zuber M, Dieterich H, Mross F, Wilber K, Simon R, Sauter G. Al-Kuraya K, et al. Cancer Res. 2004 Dec 1;64(23):8534-40. doi: 10.1158/0008-5472.CAN-04-1945. Cancer Res. 2004. PMID: 15574759

7

Predominance of high-grade pathway in breast cancer development of Middle East women.

Al-Kuraya K, Schraml P, Sheikh S, Amr S, Torhorst J, Tapia C, Novotny H, Spichtin H, Maurer R, Mirlacher M, Simon R, Sauter G. Al-Kuraya K, et al. Mod Pathol. 2005 Jul;18(7):891-7. doi: 10.1038/modpathol.3800408. Mod Pathol. 2005. PMID: 15803183 Free article.

8

Tissue microarrays for comparing molecular features with proliferation activity in breast cancer.

Ruiz C, Seibt S, Al Kuraya K, Siraj AK, Mirlacher M, Schraml P, Maurer R, Spichtin H, Torhorst J, Popovska S, Simon R, Sauter G. Ruiz C, et al. Int J Cancer. 2006 May 1;118(9):2190-4. doi: 10.1002/ijc.21581. Int J Cancer. 2006. PMID: 16331604

9

Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis.

Al-Kuraya KS, Bavi PP, Ezzat AA, Al-Dayel FA, Uddin S, Atizado VL, Al-Jomah NA, Amr SS, Sheikh SS, Sauter G, Simon R. Al-Kuraya KS, et al. Saudi Med J. 2006 Mar;27(3):323-8. Saudi Med J. 2006. PMID: 16532091

10

High epidermal growth factor receptor amplification rate but low mutation frequency in Middle East lung cancer population.

Al-Kuraya K, Siraj AK, Bavi P, Al-Jommah N, Ezzat A, Sheikh S, Amr S, Al-Dayel F, Simon R, Guido S. Al-Kuraya K, et al. Hum Pathol. 2006 Apr;37(4):453-7. doi: 10.1016/j.humpath.2005.12.004. Epub 2006 Mar 6. Hum Pathol. 2006. PMID: 16564920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters